These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15949506)

  • 1. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
    De Stefano N; Bartolozzi ML; Guidi L; Stromillo ML; Federico A
    J Neurol Sci; 2005 Jun; 233(1-2):203-8. PubMed ID: 15949506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.
    Arnold DL; Riess GT; Matthews PM; Francis GS; Collins DL; Wolfson C; Antel JP
    Ann Neurol; 1994 Jul; 36(1):76-82. PubMed ID: 8024266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions.
    Narayanan S; Fu L; Pioro E; De Stefano N; Collins DL; Francis GS; Antel JP; Matthews PM; Arnold DL
    Ann Neurol; 1997 Mar; 41(3):385-91. PubMed ID: 9066360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR spectroscopy in multiple sclerosis.
    De Stefano N; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():31S-35S. PubMed ID: 17425732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging neuronal and axonal degeneration in multiple sclerosis.
    De Stefano N; Guidi L; Stromillo ML; Bartolozzi ML; Federico A
    Neurol Sci; 2003 Dec; 24 Suppl 5():S283-6. PubMed ID: 14652790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between diffuse axonal damage and fatigue in multiple sclerosis.
    Tartaglia MC; Narayanan S; Francis SJ; Santos AC; De Stefano N; Lapierre Y; Arnold DL
    Arch Neurol; 2004 Feb; 61(2):201-7. PubMed ID: 14967766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A; Corkill R; Blamire AM; Palace J; Narayanan S; Arnold D; Styles P; Matthews PM
    J Neurol; 2003 Feb; 250(2):171-8. PubMed ID: 12574947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients.
    Fu L; Wolfson C; Worsley KJ; De Stefano N; Collins DL; Narayanan S; Arnold DL
    NMR Biomed; 1996 Dec; 9(8):339-46. PubMed ID: 9176888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Pascual AM; Martínez-Bisbal MC; Boscá I; Valero C; Coret F; Martínez-Granados B; Marti-Bonmati L; Mir A; Celda B; Casanova B
    Neurology; 2007 Jul; 69(1):63-7. PubMed ID: 17606882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton MR spectroscopy in multiple sclerosis.
    Arnold DL; De Stefano N; Narayanan S; Matthews PM
    Neuroimaging Clin N Am; 2000 Nov; 10(4):789-98 ,ix-x. PubMed ID: 11359725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability.
    De Stefano N; Narayanan S; Francis GS; Arnaoutelis R; Tartaglia MC; Antel JP; Matthews PM; Arnold DL
    Arch Neurol; 2001 Jan; 58(1):65-70. PubMed ID: 11176938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.
    De Stefano N; Narayanan S; Matthews PM; Mortilla M; Dotti MT; Federico A; Arnold DL
    J Neurovirol; 2000 May; 6 Suppl 2():S121-9. PubMed ID: 10871799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging axonal damage in multiple sclerosis by means of MR spectroscopy.
    De Stefano N; Narayanan S; Mortilla M; Guidi L; Bartolozzi ML; Federico A; Arnold DL
    Neurol Sci; 2000; 21(4 Suppl 2):S883-7. PubMed ID: 11205368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.
    De Stefano N; Matthews PM; Fu L; Narayanan S; Stanley J; Francis GS; Antel JP; Arnold DL
    Brain; 1998 Aug; 121 ( Pt 8)():1469-77. PubMed ID: 9712009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review.
    Caramanos Z; Narayanan S; Arnold DL
    Brain; 2005 Nov; 128(Pt 11):2483-506. PubMed ID: 16230321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Magnetic resonance spectroscopy and its clinical applications in multiple sclerosis].
    Watanabe H; Fukatsu H; Ito T; Iijima M; Mabuchi N; Sobue G
    Nihon Rinsho; 2003 Aug; 61(8):1435-41. PubMed ID: 12962035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility-weighted imaging and proton magnetic resonance spectroscopy in assessment of outcome after pediatric traumatic brain injury.
    Ashwal S; Babikian T; Gardner-Nichols J; Freier MC; Tong KA; Holshouser BA
    Arch Phys Med Rehabil; 2006 Dec; 87(12 Suppl 2):S50-8. PubMed ID: 17140880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological indicators of the neurodegenerative phase of multiple sclerosis.
    Zaffaroni M
    Neurol Sci; 2003 Dec; 24 Suppl 5():S279-82. PubMed ID: 14652789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
    De Stefano N; Filippi M; Miller D; Pouwels PJ; Rovira A; Gass A; Enzinger C; Matthews PM; Arnold DL
    Neurology; 2007 Nov; 69(20):1942-52. PubMed ID: 17998486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.